PNC Financial Services Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

PNC Financial Services Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-589	Closed	-$24K	–	4831
2015 Q2	$24K	Sell	589 -388,263	-100%	-$13.9M	﹤0.01%	3431
2015 Q1	$13.7M	Buy	388,852 +2,974	+0.8%	+$101K	0.02%	460
2014 Q4	$12.4M	Buy	385,878 +17,890	+5%	+$517K	0.01%	465
2014 Q3	$10.3M	Buy	367,988 +10,805	+3%	+$329K	0.01%	495
2014 Q2	$10.8M	Buy	357,183 +41,234	+13%	+$1.14M	0.01%	464
2014 Q1	$8.75M	Buy	315,949 +50,853	+19%	+$1.33M	0.01%	498
2013 Q4	$6.77M	Buy	265,096 +25,825	+11%	+$796K	0.01%	542
2013 Q3	$7.15M	Buy	239,271 +14,445	+6%	+$402K	0.01%	503
2013 Q2	$6.46M	Buy	+224,826	New	+$6.2M	0.01%	504

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

PNC Financial Services Group's BRLI Position: Q3 2015 in Review

PNC Financial Services Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 589 shares — an estimated $24K sold.

PNC Financial Services Group first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $13.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

PNC Financial Services Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
PNC Financial Services Group sold 589 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $24K.
PNC Financial Services Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
PNC Financial Services Group's BIO-REFERENCE LABS INC-NEW- position peaked at $13.7M in Q1 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on PNC Financial Services Group's 13F filing for Q3 2015, filed 6 Nov 2015.